Abstract
Objective: To investigate the effect of cucurmosin (CUS) on proliferation inhibition in the human pancreatic cancer cell line SW-1990 in vitro and in vivo.
Methods: 1. MTT assay was used to analyse the proliferation inhibition of CUS in SW-1990 cells compared with gemcitabine (GEM) in vitro. 2. We established an NOD-SCID mice orthotopic transplantation model and estimated the proliferation inhibition effect of CUS in SW-1990 cells in vivo. 3. Western blot was used to determine the protein expressions of Caspase 3, Bcl-2, Caspase 9, PI3K, Akt, mTOR, P70S6k, and 4E-BP1 after CUS intervention.
Results: 1. CUS inhibited the proliferation of pancreatic cancer cells and induced apoptosis in CUS dose- and time-dependent manners. 2. NOD-SCID mice models were established successfully, and the tumour proliferation inhibition rates of these models increased compared with the control group. 3. CUS inhibited all of the examined proteins in the PI3K/Akt/mTOR signalling pathway and induced active fragments of Caspase 3 and Caspase 9.
Conclusion: 1. CUS can inhibit the growth of SW-1990 cells in vitro and in vivo. 2. CUS can induce apoptosis in SW-1990 cells to inhibit cell growth.
Keywords: Pancreatic cancer, cucurmosin, proliferation inhibition, apoptosis.
Anti-Cancer Agents in Medicinal Chemistry
Title:Cucurmosin Kills Human Pancreatic Cancer SW-1990 Cells in vitro and in vivo
Volume: 13 Issue: 6
Author(s): Jieming Xie, Congfei Wang, Aiqin Yang, Baoming Zhang, Qiang Yin, Heguang Huang and Minghuang Chen
Affiliation:
Keywords: Pancreatic cancer, cucurmosin, proliferation inhibition, apoptosis.
Abstract: Objective: To investigate the effect of cucurmosin (CUS) on proliferation inhibition in the human pancreatic cancer cell line SW-1990 in vitro and in vivo.
Methods: 1. MTT assay was used to analyse the proliferation inhibition of CUS in SW-1990 cells compared with gemcitabine (GEM) in vitro. 2. We established an NOD-SCID mice orthotopic transplantation model and estimated the proliferation inhibition effect of CUS in SW-1990 cells in vivo. 3. Western blot was used to determine the protein expressions of Caspase 3, Bcl-2, Caspase 9, PI3K, Akt, mTOR, P70S6k, and 4E-BP1 after CUS intervention.
Results: 1. CUS inhibited the proliferation of pancreatic cancer cells and induced apoptosis in CUS dose- and time-dependent manners. 2. NOD-SCID mice models were established successfully, and the tumour proliferation inhibition rates of these models increased compared with the control group. 3. CUS inhibited all of the examined proteins in the PI3K/Akt/mTOR signalling pathway and induced active fragments of Caspase 3 and Caspase 9.
Conclusion: 1. CUS can inhibit the growth of SW-1990 cells in vitro and in vivo. 2. CUS can induce apoptosis in SW-1990 cells to inhibit cell growth.
Export Options
About this article
Cite this article as:
Xie Jieming, Wang Congfei, Yang Aiqin, Zhang Baoming, Yin Qiang, Huang Heguang and Chen Minghuang, Cucurmosin Kills Human Pancreatic Cancer SW-1990 Cells in vitro and in vivo, Anti-Cancer Agents in Medicinal Chemistry 2013; 13 (6) . https://dx.doi.org/10.2174/18715206113139990109
DOI https://dx.doi.org/10.2174/18715206113139990109 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Premature Ovarian Insufficiency and Long-Term Health Consequences
Current Vascular Pharmacology Protein Interaction Networks in Metallo Proteins and Docking Approaches of Metallic Compounds with TIMP and MMP in Control of MAPK Pathway
Letters in Drug Design & Discovery Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BMMNCs Cell
Pharmaceutical Nanotechnology Purinergic Receptors and Pain
Current Pharmaceutical Design Physiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Current Immunology Reviews (Discontinued) Anti-cancer Peptides from Ras-P21 and P53 Proteins
Current Pharmaceutical Design Prediction of Chemical Multi-target Profiles and Adverse Outcomes with Systems Toxicology
Current Medicinal Chemistry Structural Findings and Molecular Modeling Approach of a TFPI-Like Inhibitor
Protein & Peptide Letters Genetic Engineering - A New Era for Cancer Immunotherapy?
Current Cancer Therapy Reviews Quality Survival with Fertility after Gynaecological and other Cancers
Current Women`s Health Reviews Therapeutic Potential of Alpinia officinarum
Mini-Reviews in Medicinal Chemistry Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology Rapidly Increasing Trends in Oropharyngeal Carcinoma Assessed by Worldwide Epidemiologic Analysis
Current Cancer Therapy Reviews Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy
Current Pharmaceutical Design Structure-Activity Relationship Studies on ADAM Protein-Integrin Interactions
Cardiovascular & Hematological Agents in Medicinal Chemistry Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Endocannabinoid Regulation of Matrix Metalloproteinases: Implications in Ischemic Stroke
Cardiovascular & Hematological Agents in Medicinal Chemistry Patent Selections
Recent Patents on Drug Delivery & Formulation Curcumin: Powerful Immunomodulator from Turmeric
Current Immunology Reviews (Discontinued) Multifaceted Role of Neuropilins in Cancer
Current Medicinal Chemistry